Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BDSI shares surge on postive Onsolis meeting with FDA
Bizjournals.com
Friday, September 3, 2010 - 12:08pm
tags:
BioDelivery Sciences, Onsolis, FDA
Will Johnson & Johnson's Dividends Last?
Motley Fool
Friday, September 3, 2010 - 12:00pm
tags:
dividends, JNJ
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Friday, September 3, 2010 - 11:57am
tags:
Arena Pharmaceuticals, Contrave, Orexigen, Vivus, obesity, Qnexa
5-Star Stocks Poised to Pop: Gilead Sciences
Motley Fool
Friday, September 3, 2010 - 11:55am
tags:
Gilead Sciences
Celldex, Pfizer Split Over Brain Tumor Drug
TheStreet.com
Friday, September 3, 2010 - 11:54am
tags:
Celldex, Pfizer, brain tumors
Genzyme’s Termeer Could Sell Company
NY Times, NY
Friday, September 3, 2010 - 11:53am
tags:
Henri Termeer, M&A, Sanofi, Genzyme
Are Pharmaceutical Executives Hampering the Ability of their Companies to Change?
Pharmareform
Friday, September 3, 2010 - 10:48am
tags:
pharma execs
Checking for Revenue Tricks at Talecris Biotherapeutics Holdings
Motley Fool
Friday, September 3, 2010 - 10:47am
tags:
Talecris
Abbott Halts Sale of Flu Vaccine Business
NY Times, NY
Friday, September 3, 2010 - 10:46am
tags:
Abbott Laboratories, vaccines, M&A, Solvay
Yes, Roche Is Planning Those Job Cuts
Pharmalot
Friday, September 3, 2010 - 8:16am
tags:
layoffs, Roche
Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air
Seeking Alpha
Friday, September 3, 2010 - 8:10am
tags:
Genzyme, Isis Pharmaceuticals, mipomersen
Pfizer Acts on Growing Interest in Niche Drugs
Seeking Alpha
Friday, September 3, 2010 - 8:06am
tags:
Protalix BioTherapeutics, Pfizer, UPLYSO, M&A, tafamidis meglumine, FoldRx
Does Amgen Pass Buffett's Test?
Motley Fool
Friday, September 3, 2010 - 8:03am
tags:
Warren Buffett, Amgen
The 7 Most Popular High Yielders in Pharma
Motley Fool
Thursday, September 2, 2010 - 8:50pm
tags:
Pfizer, JNJ, Merck, Abbott Laboratories, Bristol-Myers Squibb, GSK, Novartis
HR Hell at Pfizer: Retiree’s Stock Options Are Cancelled in a Paperwork Error
BNET Pharma
Thursday, September 2, 2010 - 6:22pm
tags:
Pfizer, stock options
Strong Data for Transdel Pharma
Yahoo/Zacks.com
Thursday, September 2, 2010 - 6:20pm
tags:
Transdel
Two Undervalued China Pharma Stocks
TheStreet.com
Thursday, September 2, 2010 - 6:16pm
tags:
China, Skystar Bio-Pharmaceutical, China Sky One Medical
Otsuka Said to Hire Morgan Stanley, Nomura, UBS to Manage Drugmaker's IPO
Bloomberg
Thursday, September 2, 2010 - 4:21pm
tags:
Japan, Otsuka, IPOs
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thursday, September 2, 2010 - 4:01pm
tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
American Heart Association, Avandia & Ghostwriting
Pharmalot
Thursday, September 2, 2010 - 3:58pm
tags:
Avandia, GSK, diabetes, Ghostwriting

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.